the role of host factors in semliki forest virus infectiontiivistelmä – referat – abstract host...
TRANSCRIPT
-
The Role of Host Factors in Semliki Forest
VirusInfection
LauriIlmariAureliusPulkkinen
013865957
Progradu
Master’sPrograminGeneralMicrobiology
UniversityofHelsinki,DepartmentofBiosciences&InstituteofBiotechnology
SupervisedbyDr.GiuseppeBalistreri,Docent
©LauriPulkkinen,2017
-
1
Tiedekunta–Fakultet–FacultyFacultyofBiologicalandEnvironmentalSciences
Laitos–Institution–DepartmentDepartmentofBiosciences
Tekijä–Författare–AuthorLauriIlmariAureliusPulkkinenTyönnimi–Arbetetstitel–TitleTheRoleofHostFactorsinSemlikiForestVirusInfectionOppiaine–Läroämne–SubjectGeneralmicrobiologyTyönlaji–Arbetetsart–LevelProGradu
Aika–Datum–Monthandyear7/2017
Sivumäärä–Sidoantal–Numberofpages52
Tiivistelmä–Referat–AbstractHost factorsplaycrucialroles invirus infections.Virusesexploitvariouscellularprocessesand are counteracted by an arsenal of host antiviral defenses. Characterization of theseinteractions is crucial for understanding the viral life cycle and developing novel antiviraltreatments. Semliki Forest virus (SFV) is a positive-strand RNA alphavirus that has beenusedasamodelvirusformultipleclinicallysignificantdiseasessuchas lethalencephalitis.The aim of this thesis was to identify host factors that affect SFV infection to betterunderstandthebiologyofSFV,andtoprovidecandidatetargetsfortherapiesagainstmoreseriousalphavirusinfections.Here I have conducted follow up studies on a previously performed genome-wide siRNAscreen thathinted thatanumberofgeneshavenovel functions inSFV infection. Iusedanautomated high-throughput imaging-based approach to confirm the roles of these hostfactorsinSFVinfection.Forcomparison,Ialsousedasimilarstrategytotestifthesegenesaffect negative-strand RNA virus infections, using vesicular stomatitis virus (VSV).Additionally,IstudiedwhetherthehostfactorsaffectingSFVinfectionsperformtheirrolesin the entry and penetration, or post-penetration steps using a previously developedendocyticbypassassay.Iidentifiedtheγ-aminobutyricacid(GABA)transporter,SLC6A13,asapotentialreceptorforSFV.IalsodescribeothernovelgenesthathaverolesinSFVorVSVinfections.Inaddition,IshowthatTNP01,RPL18,ETF1,DMN2,andGNDPA1promote,andHDAC6counteractsSFVinfection in the entry andmembrane penetration steps. Furthermore, I report that in thelater stages of the infection DDX54 boosts and EIF2B3, EIF4G1, PHB2, EDF1, DDX47, andDHX57hinderSFV.Avainsanat–Nyckelord–KeywordsHost-virusinteractions,siRNA,Automatedhigh-throughputmicroscopy,RNAvirus,SLC6A13,GAT-2,SemlikiForestvirus,VesicularstomatitisvirusOhjaajataiohjaajat–Handledare–SupervisororsupervisorsGiuseppeBalistreriSäilytyspaikka–Förvaringställe–WheredepositedViikkiScienceLibrary/YMBOlibraryMuitatietoja–Övrigauppgifter–Additionalinformation
-
2
Tiedekunta–Fakultet–FacultyBio-jaympäristötieteellinentiedekunta
Laitos–Institution–DepartmentBiotieteidenlaitos
Tekijä–Författare–AuthorLauriIlmariAureliusPulkkinenTyönnimi–Arbetetstitel–TitleTheRoleofHostFactorsinSemlikiForestVirusInfectionOppiaine–Läroämne–SubjectYleinenmikrobiologiaTyönlaji–Arbetetsart–LevelProGradu
Aika–Datum–Monthandyear7/2017
Sivumäärä–Sidoantal–Numberofpages52
Tiivistelmä–Referat–AbstractIsäntäsolujenproteiinitovatmerkittävässäroolissavirusinfektioissa.Viruksethyödyntäväthuomattavaa määrää isäntiensä luontaisista ominaisuuksista, ja solut puolustautuvatviruksia vastaan monin tavoin. Virusten ja isäntäsolujen välisten vuorovaikutustenselvittäminen on välttämätöntä virusten biologian ymmärtämiseksi. Näidenvuorovaikutustentunteminenonmyöstärkeäävirusinfektioitahoidettaessa.SFV (Semliki forest virus) on positiivisjuosteinen RNA-virus, joka toimii malliviruksenamonille taudeille, kuten tappavalle virusaivokuumeelle. Tässä pro gradu -tutkielmassatavoitteenani oli löytää uusia geenejä, jotka toimivat SFV-infektioissa. Akateemisenmielenkiinnon tyydyttämisen lisäksi uusien SFV-infektioihin liittyvien proteiinientunnistaminen voi auttaa uusien hoitomuotojen kehittämiseksi vakavampia virustautejavastaan.Aikaisempi genominlaajuinen siRNA-kartoitus paljasti joukon geenejä, jotka saattavatvaikuttaa SFV-infektioihin. Tässä tutkielmassa selvitin näiden vaikutusta SFV-infektioihinkäyttäen siRNA-teknologiaa sekäautomatisoituakuvantamista ja kuva-analyysiä.Vertailunvuoksi selvitin myös, kuinka nämä geenit vaikuttavat negatiivisjuosteisten RNA-virusteninfektioihin käyttäen VSV-virusta (Vesicular stomatitis virus). Tämän lisäksi selvitin,toimivatkoSFV-infektioonvaikuttavatproteiinitinfektionalku-vailoppuvaiheissa.Havaitsin,ettäγ-aminovoihappoa(GABA)kuljettavaproteiiniSLC6A13,saattaatoimiaSFV-viruksen reseptorina. Löysin myös muita SFV- ja VSV-infektioihin vaikuttavia geenejä.Huomasinmyös,ettäTNP01-,RPL18-,ETF1-,DMN2- jaGNDPA1-proteiinejatarvitaanSFV-infektion alkuvaiheissa. Tämän lisäksi selvitin, että DDX54-proteiini edistää ja EIF2B3-,EIF4G1-,PHB2-,EDF1-,DDX47jaDHX57-proteiinitestävätSFV-infektiotavaikuttamallasenmyöhäisiinvaiheisiin.Avainsanat–Nyckelord–KeywordsVirus-isäntäsoluvuorovaikutus,siRNA,Automatisoitumikroskopia,RNA-virus,SLC6A13,GAT-2,Semlikiforestvirus,VesicularstomatitisvirusOhjaajataiohjaajat–Handledare–SupervisororsupervisorsGiuseppeBalistreriSäilytyspaikka–Förvaringställe–WheredepositedViikintiedekirjasto/YleisenmikrobiologianosastonkäsikirjastoMuitatietoja–Övrigauppgifter–Additionalinformation
-
3
DeclarationofauthorshipThe work presented in this thesis is my own and performed as a part of my
master’s thesis project, except for the following: I amplified and titered the
SemlikiForestvirusexpressingZsGreen,andvalidatedthehostfactorsinvolved
in Semliki Forest virus infection as a part of the course “Research Project in
Virology1” (528041).Dr.GiuseppeBalistreri andDr.KirsiHellströmgrew the
BHK-21 cells, and Dr. Giuseppe Balistreri amplified the recombinant vesicular
stomatitisvirusexpressingthegreenfluorescentprotein.
-
4
Contents1. Listofabbreviations...........................................................................................................6
2. Introduction
2.1. Virus-hostinteractions.....................................................................................................7
2.2. SemlikiForestvirusandvesicularstomatitisvirus.......................................................9
2.3. TheroleofhostfactorsinSFVinfection.....................................................................................11
3. Materialsandmethods
3.1. Celllinesandviruses......................................................................................................13
3.2. Virusproductionandtitration........................................................................................................13
3.3. VirusinfectionsofsiRNA-transfectedcells...............................................................................14
3.4. Endocyticbypassassay..................................................................................................15
3.5. Automatedhigh-throughputimageanalysis...............................................................16
4. Results
4.1. KnockingdownpreviouslyimplicatedhostfactorsaffectsSFVandVSV
infections.........................................................................................................................17
4.2. LowpH-inducedPMfusioncanbeusedtobypassthenormalentryandpenetration
stepsofSFVinfection.....................................................................................................25
4.3. SLC6A13isneededintheearlystagesofSFVinfection.............................................27
4.4. TNP01andHDAC6affecttheentryandpenetrationstepsofSFVinfection...........30
4.5. Componentsofthetranslationmachineryaffectpenetrationandpost-penetration
stepsofSFVinfection.....................................................................................................30
4.6. SFVinfectionisaffectedbyotherhostfactorsinpenetrationandpost-penetration
steps.................................................................................................................................33
5. Discussion
5.1. HostfactorsinSFVandVSVinfections........................................................................36
-
5
5.2. SLC6A13isacandidatereceptorforSFV.....................................................................37
5.3. HostfactorsthataffectSFVinfection...........................................................................38
5.4. Otherhostfactors...........................................................................................................42
5.5. Methodologicalconsiderations.....................................................................................44
5.6. Conclusions.....................................................................................................................45
6. Acknowledgements..........................................................................................................45
7. References............................................................................................................................46
8. Supplementaryinformation.........................................................................................52
-
6
1.ListofabbreviationsAP2 Adaptorcomplex2 kb kilobase
AP2M1 Adaptorrelatedproteincomplex2μ1 KIF11 Kinesinfamilymember11
ATP Adenosinetriphosphate KPNB1 karyopherinsubunitβ1
ATP6V1B2 ATPaseH+transportingV1subunitB2 KREMEN2 Kringlecontainingtransmembrane
protein2
ATP6V1G1 ATPaseH+transportingV1subunitG1 MEM MinimumEssentialMedium
BSA Bovineserumalbumin miRNA Micro-RNA
CLTC Clathrinheavychain mRNA MessengerRNA
CSPG5 Chondroitinsulfateproteoglycan5 NRAMP2 Naturalresistanceassociated
macrophageprotein2
DDX DEAD-boxhelicase nsP Non-structuralprotein
DHX DEAH-boxhelicase PBS Phosphate-bufferedsaline
DMEM Dulbecco’sModifiedEagle’sMedium PFA Para-formaldehyde
DMN2 Dynamin-2 PHB2 Prohibitin-2
EDF1 EndothelialDifferentiationRelated
Factor1
PM Plasmamembrane
EIF2B3 Eukaryotictranslationinitiationfactor
2Bsubunitγ
PPBI CyclophilinB(human)
EIF4G1 Eukaryotictranslationinitiationfactor
γ1
Ppbi CyclophilinB(mouse)
ESCRT Endosomalsortingcomplexes
requiredfortransport
PVR Poliovirusreceptor
ETF1 Eukaryotictranslationtermination
factor1
+RNA Positive-strandRNA
FBS Fetalbovineserum -RNA Negative-strandRNA
GABA γ-aminobutyricacid RPL18 RibosomalproteinL18
GAT-2 GABAtransporter2 RT Roomtemperature
GDP Guanosinediphosphate SFV SemlikiForestvirus
GFP Greenfluorescentprotein siRNA SmallinterferingRNA
GNPDA1 Glucosamine-6-phosphatedeaminase
1
SLC6 Solutecarrierfamily6
GTP Guanosinetriphosphate SLC6A13 Solutecarrierfamily6member13
HCV HepatitisCvirus TNP01 Transportin-1
HDAC Histonedeacetylase UPF1 Regulatorofnonsensetranscripts-1
HDAC6 Histonedeacetylase6 UTR Untranslatedregion
HIV-1 Humanimmunodeficiencyvirus1 vATPase VesicularATPase
IAV InfluenzaAvirus VSV Vesicularstomatitisvirus
-
7
2.Introduction
2.1Virus-hostinteractions
Asobligateparasites,virusesrequirediversecellularfactorsforthecompletion
oftheir lifecycles.Virusesusehost factorstobindandentercellsaswellasto
replicatetheirgenomesandproducenewvirions.Ontheotherhand,anumber
ofhostproteinsworktocounteractviralinfection.
Toinitiatesuccessful infection,virusesneedtobindtothesurfaceoftheirhost
cells. Inanimalcells, thisprocess ismediatedbyhost’sattachment factorsand
virusreceptors,whicharecommonlycellssurfaceglycoproteinsandglycolipids
(Smith & Helenius, 2004). Attachment factors bind the virus on the plasma
membrane (PM) of the host, often via non-specific electrostatic interactions
(Grove&Marsh,2011)(Figure1A).Thisinitialbindingallowstheboundvirion
torecruitthereceptormoleculesthatinitiatetheentryprocess(Grove&Marsh,
2011)(Figure1B).Virusentryisusuallymediatedbyendocytosis,aprocessby
whichthecellisabletointernalizeportionsofthePMandextracellularsolutes,
suchasnutrientsandhormones(Marsh&Helenius,2006).Multipleendocytosis
mechanisms exist and they canbe roughlydivided to two categoriesbasedon
the volume of the endocytic vesicle and the mechanism of vesicle formation
(Doherty &McMahon, 2009). In “micropinocytosis”, such as clathrin-mediated
endocytosis,thevesicleisformedbyinvaginationsofthePMandsmallvolumes
of the extracellular medium are internalized (Doherty & McMahon, 2009).
MacropinocyticvesiclesaretheresultofPMprotrusionsthat“grab”extracellular
mediumor even other cells (phagocytosis) and then fuse back to thePMwith
their cargo (Doherty&McMahon, 2009). Different viruses, such as hepatitis C
virus (HCV) (clathrin-mediated endocytosis) or Kaposi’s sarcoma-associated
herpesvirus (macropinocytosis) are able to exploit the full variety of these
processes(Meertensetal,2006;Raghuetal,2009;Merceretal,2010).
Recruiting the endocytic machinery gives viruses multiple advantages over
penetrating the PM directly. Internalizing the entire virion prevents the
accumulationofpotentiallyantigenicviralcomponentsonthehostsurface,gives
-
8
the virus a convenientway to infiltrate deep into the cell, and gives the virus
access to intracellular compartmentswhere chemical cuesdestabilize theviral
particle and initiate the disassembly process known as uncoating (Marsh &
Helenius,2006).ThesecuesareeitherchangesinthepHoftheendosomeorthe
action of endosomal enzymes (Grove & Marsh, 2011). The conditions of the
endosome cause conformational changes in the viral fusion proteins, which
allows the virus to penetrate the endosomal membrane into the cytoplasm
(Grove&Marsh,2011).Thisresultsinthedeliveryoftheviralnucleocapsidinto
thesiteofuncoatingand/orreplication(Grove&Marsh,2011)(Figure1D).
Thenext step in theviral life cycle is the transcriptionand translationof viral
messengerRNAs(mRNAs),orinthecaseofpositive-strand(+RNA)viruses,the
direct translation of the viral genome. RNA viruses use their own RNA-
dependentRNApolymerases for transcriptionbut theyusehostmachinery for
translation, which leads to a translational competition between host and viral
RNAs(Walsh&Mohr,2011)(Figure1E).Thisinteractionisfurthercomplicated
by host antiviral defenses that aim to shut down translation (Walsh & Mohr,
2011). Therefore it is understandable that viruses have evolved myriad
mechanismstousurptheproteinsynthesismachineryofthehostandtokeepit
operationaldespitehostantiviralresponse(Walsh&Mohr,2011).
Once the cell is under viral control, the final stage of the infectionbegins. The
viralgenomeisreplicatedandprogenyvirionsareassembledbyexploitinghost
resourcesandstructures,suchasthePM,theendoplasmicreticulum,ortheGolgi
apparatus(Kuismanenetal,1982;Gosertetal,2003;Spuuletal,2010)(Figure1
E).Oncethenewgenerationofvirions isready, theyexit thecellusingvarious
strategies. Virusesmay, for example, use the host’s ESCRT (endosomal sorting
complexes required for transport) system and bud from the PM (Votteler &
Sundquist,2014),useanexocytosis-likepathway (Johnson&Baines,2011),or
causethelysisofthehostcell(Tollefsonetal,1996)(Figure1F).
Asvirusinfectionishighlydependentonhostfunctions,elucidatingtheinterplay
between viral and cellular factors is crucial in understanding the biology of
-
9
viruses. Observing host-virus interactions also plays a key role in the
development of new treatments and therapies. In addition, by following the
different stages of virus infections, it is possible to assign novel functions to
poorlycharacterizedcellularfactors.
Figure1.The lifecycleofanendocytosis-utilizingenvelopedvirus.A:Thevirusinfectionbeginswithnon-specificbindingonhostattachment factorssuchasheparansulphate.B:Non-specificbinding leads toreceptorrecruitmentC:Receptorbindingisoftenmultivalentandtriggerstheendocytosisevent.D:Theendosomecarriesthevirusdeeperintothecellusing the tubularnetwork.Endosomalenzymesand/or theacidificationof theendosomebytheactionofhostvesicular ATPases (vATPases) leads to a conformational change in the viral spike proteins. This allows a membranefusioneventtooccur,whichreleasesthenucleocapsidintothecytosol.Theviralgenomeisuncoatedandtransportedtoits replicationsite.E:ViralRNAoutcompeteshostmRNAby limitinghost transcriptionorpreventinghost translation.Thisleadstotheproductionofviralproteinsandthereplicationoftheviralgenome.F:Theviralcomponentsassembleintonucleocapsids,whichexitfromthecellse.g.bybuddingfromthePM.
2.2SemlikiForestvirusandvesicularstomatitisvirus
Semliki Forest virus (SFV) is one of the best-studied members of the genus
Alphavirus. Like other alphaviruses, it is a +RNA virus that infects both
invertebrateandvertebratehosts(Griffin,2013).SFVvirionsareenvelopedand
haveadiameterof70nm,withicosahedrallysymmetricnucleocapsids(Mancini
etal,2000).SFVentershostcellsusingendocytosisandpenetratestheendocytic
vesicle after a low pH-induced conformational change in the SFV spike
glycoproteinsleadstothefusionofviralandendosomalmembranes(Heleniuset
al, 1980; White et al, 1980; Fuller et al, 1995). Once in the cytosol, the
nucleocapsid is immediately engaged by host ribosomes, which triggers the
-
10
uncoatingof thenucleocapsidand leads toviral translation (Singh&Helenius,
1992).The lowpHof theendosomes (
-
11
2013).However,VSVfusionoccurslaterthanSFVfusionanditismediatedbya
two-step fusion program (Le Blanc et al, 2005). First the VSV nucleocapsid is
releasedtothelumenofanintra-endosomalvesicleanditentersthecytoplasm
later, following a back-fusion of the intra-endosomal vesicle (Le Blanc et al,
2005). The transcription and replication of VSV follows the general scheme of
non-segmented -RNA viruses (Lyles et al, 2013). The genome is used as a
templateforviralmRNAsanda+RNA-antigenome,whichisusedastemplatefor
thenew-RNAgenomes.
2.3TheroleofhostfactorsinSFVinfection
Previously,agenome-widesiRNAscreenwasperformedtoidentifyhostfactors
thataffectSFVinfection(Balistrerietal,2014).Thescreenimplicatedanumber
ofgenes(“hits”) (Table1).Following thescreen, therolesofUPF1,ATP6V1B2,
andATP6V1G1inSFVinfectionwerecharacterized(Balistrerietal,2014).
Table1.GenesimplicatedinSFVinfectionbythegenome-widesiRNAscreen.
Genesymbol Function GeneID* Genesymbol Function GeneID*PHB2 Intracellular
signaling11331 DDX31 DEAD-box
helicase64794
EDF1 Transcriptionalcoactivation
8721 DDX41 DEAD-boxhelicase
51428
SLC6A13 GABA&taurinetransport
6540
DDX43 DEAD-boxhelicase
55510
EIF2B3 Translationinitiation
8891
DDX47 DEAD-boxhelicase
51202
ETF1 Translationtermination
2107 DDX54 DEAD-boxhelicase
79039
EIF4G1 Translationinitiation
1981 DHX37 DEAH-boxhelicase
57647
DDX18 DEAD-boxhelicase 8886
DHX57 DEAH-boxhelicase
90957
PVR Poliovirusreceptor 5817
KREMEN2 Transmembranereceptor
79412
CSPG5 Chondroitinsulfateproteoglycan5
10675
HDAC6
Deacetylationofvariousproteins
10013
GNPDA1 Glucosamine-6-phosphatedeaminase
10007
DNM2 Endocytosis 1785
RPL18 Ribosomalprotein 6141
AP2M1 VacuolarATPaseactivation
1173
UPF1 mRNAqualitycontrol,antiviral
activity
5976
CLTC Endocytosis 1213
ATP6V1B2 Vesicleacidification
526
KPNB1 Nuclearlocalization
3837
ATP6V1G1 Vesicleacidification
9550 TNPO1 Intracellularlocalization
3842
*O’Learyetal,2016
-
12
The firstaimof this thesiswastoconfirmtherolesof thehits inSFV infection
and investigate if their effectwas specific to SFV. Thiswas done using siRNA-
mediated knockdown and high-throughput imaging to determine if the hits
affectedSFVandVSVinfections.Thesecondaimwastoassignaroleintheearly
(entry andpenetration), or later (post-penetration) stages of SFV infection for
theconfirmedhostfactors.Thiswasperformedusingasimilarstrategyasabove
combinedwithanassaytobypasstheendocytosisstepofSFVinfection(Whiteet
al,1980)(Figure2).
Figure 2. The aim of this thesis. Previously, a genome-wide image-based siRNA screen identifiednumerouscandidates(or“hits”)forSFVinfectionaffectinghostgenes.Inthisthesis,Ihaveanalyzedtheirrole invirus infectionsusingsmall-scale image-basedsiRNAknockdownstudies. I confirmed if thesehitshadaroleinSFVinfectionandtestediftheyaffectedVSVinfectionforcomparison.ForthegenesaffectingSFV infection, I further studied if their role was related to either the entry and penetration, or post-penetration stages of the infection. The genome-wide screen image was kindly provided by GiuseppeBalistreri.
InthisthesisIdescribenovelgenesaffectingSFVinfection,aswellasnovelhost
factorswitharoleinVSVinfection.Ialsopinpointtheeffectsofgenesinvolvedin
SFV infectiontoentryandpenetration,orpost-penetrationsteps. Inaddition, I
show that SLC6A13, a membrane-spanning γ-aminobutyric acid (GABA) and
taurinetransporter(Kristensenetal,2011;Zhouetal,2012), isneededforthe
earlyeventsofSFVinfection,buthasnoroleinVSVinfection,andisthereforea
candidatereceptorforSFV.
-
13
3.Materialsandmethods3.1Celllinesandviruses
HeLa cells (ATCC) were cultured using Dulbecco’s Modified Eagle’s Medium
(DMEM) (Sigma-Aldrich, D7777) supplementedwith 10% fetal bovine serum
(FBS) (Sigma-Aldrich, F9665), GlutaMAX (Gibco, 35050-061), Non-essential
Amino Acids Solution (Sigma-Aldrich, M7145), and Antibiotics & Antimycotics
Solution (Sigma-Aldrich, A5955) (HeLa growthmedium). BHK-21 cells (ATCC)
were culture using Minimum Essential Medium (MEM) (Gibco, 61100-087)
supplementedwith 10% FBS and GlutaMAX. The cellswere grown at +37 °C
witha5%CO2atmosphere.
SFVexpressingZsGreenproteinfusedwiththevirusnsP3(SFV-ZsGreen)(Spuul
et al, 2010) and rVSV-GFP, a VSV strain expressing green fluorescent protein
(GFP)(Pelkmansetal,2005)havebeenpreviouslydescribed.Theviruseswere
originally produced at ETH Zurich (Switzerland) and were provided by Dr.
BalistreriwithpermissionfromprofessorAriHelenius.
3.2Virusproductionandtitration
VirusinoculawerepreparedinMEMsupplementedwith20mMHEPES(pH7.2),
GlutaMAX, and0.2%bovine serumalbumin (BSA)andconfluentBHK-21cells
were washed twice with phosphate-buffered saline (PBS) and infected with
eitherSFV-ZsGreenorrVSV-GFPusinganMOIof0.01byreplacingtheoldmedia
withthevirusinocula.Theinfectedcellswereincubatedat+37°Cwitha5%CO2
atmosphere.Themediawerecollectedafter22handcentrifugedat3900rpmfor
20 min (SFV-ZsGreen) or 10 min (rVSV-GFP) at +4 °C (Eppendorf Centrifuge
5810R)toeliminatecelldebris.Thesupernatantswerecollected,aliquotedand
storedat-80°C.
HeLacellswereseededontoblackclear-bottom96-wellplates(Corning,07-200-
568)atadensityof10000cells/wellandgrownfor16–20hat+37°Cwitha
5% CO2 atmosphere. The cells were washed with DMEM supplemented with
GlutaMAXandAntibiotics&AntimycoticsSolution(SFV-ZsGreen)orRPMI-1640
-
14
medium(ICN,1060122)containing20mMHEPESpH7.0andGlutaMAX(rVSV-
GFP) (100μl /well). The cellswhere then infectedwith1:2 (SFV-ZsGreen) or
1:10 (rVSV-GFP) serial dilutions in duplicate using 100 μl of virus inocula in
correspondingmediaTheinfectedcellsweregrownfor6h(SFV-ZsGreen)or7h
(rVSV-GFP)at+37°Cwitha5%CO2atmosphere.
After the incubation, themediawere aspirated and the cellswere fixed for20
minatroomtemperature(RT)using4%para-formaldehyde(PFA)inPBS(100
μl/well).Thefixedcellswerewashed3timeswithPBS(100μl/well).Thecells
werepermeabilizedandthenucleistainedbyincubatingthecellsfor10minat
RTin100μlofPBScontaining0.2%TritonX-100andHoechstDNAstain(1μg/
ml)perwell.Thecellswerethenwashed3timeswithPBS(100μl/well)andthe
plates covered with Black TopSeal-A plate seals (PerkinElmer, 6050173) and
storedat+4°C.Theplateswere imagedwithahigh-contentCellinsight Imager
microscope (Thermo Fisher) at the Light Microscopy Unit, Institute of
Biotechnology.16 imageswere takenperwell, usingboth the386nmand the
485nmfilterstovisualizethefluorescencesignaloftheHoechstandtheZsGreen
orGFP.TheimageswereanalyzedusingtheopensourceCellprofiler2software
(Carpenteretal,2006,www.cellprofiler.com)(seebelow).
3.3VirusinfectionsofsiRNA-transfectedcells
HeLa cells were reverse transfected using pooled siRNAs (Dharmacon
SMARTpoolsiRNAs)onablackclear-bottom96-wellplateusingaseparatewell
for each siRNA pool. The siRNA pools contained a mixture of 4 different
oligonucleotides against non-overlapping regions of each target gene in
equimolarconcentrations.ThesiRNApoolstargetedthegenesofinterestaswell
ascontrolgenes(KIF11,PpbiandPPBI)(tableS1).ThesiRNApoolagainstKIF11
wasusedasatransfectioncontrol.Sincetheproductofthisgeneisessentialfor
cell survival, monitoring cell death was used as a means to make sure the
transfectionwasefficient(>98%celldeathindicatedsuccessfultransfection).A
mixof4differentnon-specific (or “scrambled”)siRNAswasusedasanegative
controlinfourseparatewells.ThesiRNAsagainstPpbiandPPBIweresupplied
bythemanufactureraseasilyquantifiabletransfectioncontrols.
-
15
Foreachwell,10μlofasiRNAstock(100nM)wasmixedwith10μlofDMEM
containing0.1μl ofLipofectamine2000 (Invitrogen,11668-019)and theplate
was incubated at RT for 30–60 min. Then for each well, 2000 HeLa cells
suspended in 80 μl ofDMEMweremixedwith the siRNA–Lipofectamine 2000
mixyieldinga finalsiRNAconcentrationof10nMperwell.Theplatewasthen
incubatedat+37°Cwitha5%CO2atmospherefor6h,afterwhich,themedium
wasreplacedwithHeLagrowthmedium(200μl/well)andthecellsweregrown
at+37°Cwitha5%CO2atmosphere.
After72h theoldmediawereremovedand thecellswerewashedwitheither
DMEM supplemented with GlutaMAX and Antibiotics & Antimycotics Solution
(SFV-ZsGreen)orRPMI-1640medium(ICN,1060122)containing20mMHEPES
pH7.0andGlutaMAX (rVSV-GFP) (100μl /well).Thecellswere then infected
with100μl/wellofvirusinoculacontaining6*104pfuofeitherSFV-ZsGreenor
rVSV-GFPincorrespondingmedia.Thecellswereincubatedat+37°Cwitha5%
CO2atmospherefor5h(SFV-ZsGreen)or6.5h(rVSV-GFP)andtheplateswere
fixed, stained, imaged, and analyzed as above. Three biological repetitions per
viruswereperformed.
3.4Endocyticbypassassay
HeLacellswerereverse transfectedasabove.72hafter transfection, theplate
wasplacedoniceandcellswashedwithice-coldRPMI-1640mediumcontaining
20mMHEPES,pH7.0(100μl/well)andinfectedonicewith6*104pfuofSFV-
ZsGreen diluted in the samemedium (ice-cold) (100 μl /well). The platewas
incubatedonicefor1handthemediumwasremovedfromthewells.Toallow
virus fusion with the PM, the cells were treated with RPMI-1640 medium
containing 10 mM MES buffer, pH 5.5 for 90 s at +37 °C. The medium was
aspirated and replaced with HeLa growth medium supplemented with 20mM
NH4Cland20mMHEPES,pH7.2(200μl/well).Theplatewasincubatedat+37
°Cwith5%CO2atmospherefor4handtheplatewasfixed,stained,imaged,and
analyzedasabove.Controlsincludedwellsthatwerenotinfected,wellstreated
withpH7.0mediuminsteadofthepH5.5medium,andwellstreatedwithpH7.0
-
16
medium and HeLa growth medium instead of the pH 5.5 medium and HeLa
growth medium with NH4Cl, respectively. Three biological repetitions were
performed.
3.5Automatedhigh-throughputimageanalysis
The Cellprofiler 2 software (Carpenter et al, 2006, www.cellprofiler.com) was
usedtodeterminethepercentageof infectedcells ineachwell. Ineach image,
thenumberofcellswasdeterminedbydetectingthe386nmfluorescencesignal
ofthestainednuclei,designated“primaryobjects”(Figure3A&B).SFV-ZsGreen
producesZsGreen-labelednsP3,thusZsGreen-expressingcellsareinfectedwith
SFV. For the SFV experiments the perimeter of each detected nucleus was
digitally expanded to include a portion of the cytoplasm around the nucleus,
designated“secondaryobjects”(Figure3C,D,E&F).Thiswasdonetodetectthe
ZsGreensignalfromthecytoplasm,wheretheSFVproteinsynthesisoccurs.The
mean fluorescence signal on the 485nm channel (ZsGreen)wasmeasured for
each secondary object. For the rVSV-GFP-infected cells themean fluorescence
signalon the485nmchannel (GFP)wasmeasuredwithineachprimaryobject
(nucleus), as the GFP protein encoded by the virus was synthesized in the
cytoplasmand freelydiffused into thenucleusof thehost indicatingsuccessful
viraltranslation.
Usingathresholdvalueofmean485nmfluorescence,thecellswereclassifiedin
two categories: infected (above threshold) andnon-infected (below threshold)
(Figure4G).Non-infectedcellswerealwaysincludedtocalibratethethreshold
settings for each imagedplate.Once all images in eachwell of a 96well plate
wereanalyzed,thefinalresultswereexpressedastotalinfectedcellsperwell.To
calculatevirustiters, theestimatedamountofcellsperwell(16,000)(Rafferty,
1985) was multiplied with the percentage of infected cells to determine the
amountofinfectiousvirionsperwell.InthesiRNAexperiments,cellstransfected
with non-targeting (or “scrambled”) siRNAs were used as controls. Themean
numberofinfectedcellsinthescrambledcontrolswassetas1andtheinfection
percentages in the remaining transfected wells were normalized accordingly.
The mean infection percentage per gene was calculated from three biological
-
17
repetitions. A difference of 2 or more standard deviations from controls was
consideredtobesignificant.
Figure3.AutomateddetectionofinfectedcellsusingCellprofiler2.A&B:Fluorescencesignaldetectedusing395nm(blue)and485nm(green)filtersfromSFV-infectedcellspre-treatedwithscrambledcontrolsiRNA. C: Automatically detected nuclei (pseudocoloured 'primary objects'). E–F: Pseudocolouredsecondaryobjectsobtainedbydigitallyexpandingtheprimaryobjects(D)andsubtractingtheareaoftheprimaryobjects.G:Thesecondaryobjectswereusedtoautomaticallyclassifyinfected(red)ornon-infected(blue)cells,usingthemeanfluorescenceintensityfromthe485nmchannel(G).
4.Results
The aim of this thesiswas to study the effects of knocking down host factors
previously implicated in SFV infection, and compare those effects to VSV
infection. The genes affecting SFV infection were further characterized by
studying if theyaffectentryandpenetration,orpost-penetrationstagesofSFV
infection.
4.1KnockingdownpreviouslyimplicatedhostfactorsaffectsSFVandVSV
infections
To determine which of the previously implicated genes affect SFV and VSV
infections, I used siRNA-mediated knockdown, high-throughput imaging and
automated image analysis. I found that both SFV and VSV infection could be
reducedsignificantlybyknockingdownATP6V1B2andATP6VG1,twosubunits
ofavacuolarATPaseknowtoaffectSFVinfection(Balistrerietal,2014)aswell
-
18
as ribosomalproteinL18 (RPL18), apart of the60S ribosomal subunit (de la
Cruzetal,2015)(Figures4&5).BothSFVandVSVinfectionswereaffectedby
the knockdown of transportin-1 (TNP01), an intracellular transport molecule
(Twyffels et al, 2014), prohibitin 2 (PHB2), an intracellular signaling protein
(Bavellonietal,2015),andDEAH-boxhelicase(DHX)37,apoorlycharacterized
RNA-helicase (Gene ID: 57647) (Figures 4 &5). However, the knockdown of
these genes had the opposite effects on SFV and VSV infections, as TNP01
depletiondecreasedSFVinfectionandincreasedVSVinfectionsignificantly,and
in the case of PBH2 and DHX37 depletions SFV infection increased and VSV
infectiondecreasedsignificantly(Figures4&5).
Figure4.RelativeinfectionpercentagesincellsdepletedofhostfactorsthataffectbothSFVandVSVinfections. The relative infection percentages of siRNA-treated HeLa cells infected with SFV-ZsGreen(black)orVSV-GFP (white) are indicatedon they-axis.The siRNAsusedare indicatedon thex-axis.Theinfectionpercentageswerenormalizedbysettingthemeanofthescrambledcontrolsas1.Theerrorbarsrepresentstandarddeviationsof the treerepetitionsandanasterisksignifiesaresult that issignificantlydifferentfromthecontrol.
-
19
Figure 5. Representative images of cells depleted of host factors that affect both SFV and VSVinfections.A:HeLacellsinfectedwithSFV-ZsGreen.NucleiareshowninblueandnsP3-ZsGreen,indicatingSFV infection, is shown in green. The siRNAs used are indicated by the text in the images.B:HeLa cellsinfectedwithVSV-GFP.NucleiareshowninblueandGFP,indicatingVSVinfection,isshowningreen.ThesiRNAsusedareindicatedbythetextintheimages.Bydepletingcellsofsolutecarrierfamily6member13(SLC6A13),aGABAand
taurinetransporter(Kristensenetal,2011;Zhouetal,2012),GNPDA1,apoorly
characterized glucosamine-6-phosphate deaminase (Wolosker et al, 1998),
DEAD-boxhelicase(DDX)54,anRNA-helicasethathasatranscription-regulating
roleincells(Rajendranetal,2003;Kannoetal,2012),anddynamin-2(DMN2),
a protein involved in endocytosis (Kasai et al, 1999), SFV infection could be
significantly reduced (Figures 6 & 7). On the other hand, the knockdown of
eukaryotic translation initiation factor 2B subunit γ (EIF2B3) and eukaryotic
translation initiation factor γ 1 (EIF4G1) (Walsh & Mohr, 2011), eukaryotic
translation termination factor 1 (ETF1) (Taylor et al, 2012), UPF1, an RNA-
helicasethatpreventsSFVinfection(Balistrerietal,2014),DDX47andDHX57,
-
20
predicted RNA helicases (Gene IDs: 51202 and 90957, respectively), histone
deacetylase 6 (HDAC6), a multifunctional cellular deacetylase (Hubbert et al,
2002),andendothelialdifferentiation-related factor1(EDF1),a transcriptional
co-activator(Kabeetal,1999) increasedSFVinfectivitysignificantly(Figures6
&7).ThedepletionoftheseSFV-affectinggeneshadnosignificanteffectonVSV
infection(Figures6&7).
Figure 6. Relative infection percentages in cells depleted of host factors that affect only SFVinfection.TherelativeinfectionpercentagesofsiRNA-treatedHeLacellsinfectedwithSFV-ZsGreen(black)orVSV-GFP(white)areindicatedonthey-axis.ThesiRNAsusedareindicatedonthex-axis.Theinfectionpercentageswerenormalizedbysettingthemeanofthescrambledcontrolsas1.Theerrorbarsrepresentstandarddeviations of the tree repetitions and an asterisk signifies a result that is significantly differentfromthecontrol.
-
21
Figure 7. Representative images of cells depleted of host factors that affect only SFV infection. A:HeLacellsinfectedwithSFV-ZsGreen.NucleiareshowninblueandnsP3-ZsGreen,indicatingSFVinfection,isshowningreen.ThesiRNAsusedareindicatedbythetextintheimages.B:HeLacellsinfectedwithVSV-GFP.Nucleiareshown inblueandGFP, indicatingVSV infection, is shown ingreen.ThesiRNAsusedareindicatedbythetextintheimages.
VSV infectivity was significantly increased by the depletion of the poliovirus
receptor (PVR) (Mendelsohn et al, 1989), a Wnt/β-catenin-signaling receptor,
kringlecontainingtransmembraneprotein2(KREMEN2)(Maoetal,2002),and
adaptorrelatedproteincomplex2μ1(AP2M1),anadaptorofendocyticvesicles
and vATPases, (Heinaman, 1995) (Figures 8 & 9). Knocking down DDX18, a
poorly understood RNA-helicase (Dubaele & Chène, 2007) and karyopherin
-
22
subunitβ1(KPNB1),asubunitofanuclearimportprotein(Görlichetal,1995)
decreasedVSVinfectivitysignificantly(Figures8&9).Curiously,siRNAsagainst
bothmouseandhumancyclophilinB(PpibandPPBI,respectively)suppliedas
transfectioncontrolsbythemanufacturerincreasedVSVinfectivitysignificantly
(Figures 8 & 9). Cyclophilin B is a multifunctional signaling and anti-
inflammatoryprotein(Hoffmann&Schiene-Fischer,2014).Noneofthesegenes
hadasignificanteffectonSFVinfectivity(Figures8&9).
Figure 8. Relative infection percentages in cells depleted of host factors that affect only VSVinfection.TherelativeinfectionpercentagesofsiRNA-treatedHeLacellsinfectedwithSFV-ZsGreen(black)orVSV-GFP(white)areindicatedonthey-axis.ThesiRNAsusedareindicatedonthex-axis.Theinfectionpercentageswerenormalizedbysettingthemeanofthescrambledcontrolsas1.Theerrorbarsrepresentstandarddeviations of the tree repetitions and an asterisk signifies a result that is significantly differentfromthecontrol.
-
23
Figure 9. Representative images of cells depleted of host factors that affect only VSV infection. A:HeLacellsinfectedwithSFV-ZsGreen.NucleiareshowninblueandnsP3-ZsGreen,indicatingSFVinfection,isshowningreen.ThesiRNAsusedareindicatedbythetextintheimages.B:HeLacellsinfectedwithVSV-GFP.Nucleiareshown inblueandGFP, indicatingVSV infection, is shown ingreen.ThesiRNAsusedareindicatedbythetextintheimages.
Thedepletionofsomeofthegenesimplicatedbythegenome-widesiRNAscreen
didnothaveasignificanteffectonSFVorVSVinfection(Figures10&11).These
included chondroitin sulfate proteoglycan 5 (CSPG5), a cell surface protein
expressed in the brain (Watanabe et al, 1995), DDX31, an RNA-helicase
implicatedinrenalcancer(Fukawaetal,2012),DDX41,anRNAhelicasewitha
role in cellular immunity (Jiang et al, 2017), DDX43, a RNA and DNA helicase
(Tanuetal,2017),andclathrinheavychain(CLTC),awell-studiedendocytosis
molecule(Doherty&McMahon,2009).
-
24
Figure10.Relative infectionpercentages in cellsdepletedofhost factors thatdonotaffectSFVofVSV infections.Therelative infectionpercentagesofsiRNA-treatedHeLacells infectedwithSFV-ZsGreen(black)orVSV-GFP (white) are indicatedon they-axis.The siRNAsusedare indicatedon thex-axis.Theinfectionpercentageswerenormalizedbysettingthemeanofthescrambledcontrolsas1.Theerrorbarsrepresentstandarddeviationsof the treerepetitionsandanasterisksignifiesaresult that issignificantlydifferentfromthecontrol.
-
25
Figure 11. Representative images of cells depleted of host factors that do not affect SFV of VSVinfections.A:HeLacellsinfectedwithSFV-ZsGreen.NucleiareshowninblueandnsP3-ZsGreen,indicatingSFV infection, is shown in green. The siRNAs used are indicated by the text in the images.B:HeLa cellsinfectedwithVSV-GFP.NucleiareshowninblueandGFP,indicatingVSVinfection,isshowningreen.ThesiRNAsusedareindicatedbythetextintheimages
4.2LowpH-InducedPMfusioncanbeusedtobypassthenormalentryand
penetrationstepsofSFVinfection
To determine if depleted host factors play a part in the early stages (entry or
penetration) of SFV infection, these steps were circumvented by artificially
inducingviralenvelopefusionatthePM(Whiteetal,1980).Thiswasachieved
by allowing the viruses to bind cells on ice and treating the cells quicklywith
acidicmedium (pH5.5).This causes a conformational change in the SFV spike
-
26
proteins, which leads to membrane fusion, delivery of nucleocapsid into the
cytoplasm,anduncoatingofthenucleocapsid.Sincewithinthe90secondoflow-
pH treatment, someSFVvirions are internalizedby endocytosis, after the acid
treatment cells were incubated in NH4Cl-containing medium at pH 7.2 which
neutralized the acidic pH of endosomes preventing these viruses from fusing
(Figure12).ComparedtothenormalrouteofSFVinfection,theendocyticbypass
wasslightlylessefficient,restoringabout60%ofinfectedcells.Ifthecellswere
nottreatedwithacidicmedium,butincubatedinNH4Cl-containingmedium,the
infectionpercentagedroppedtothelevelofnon-infectedwells(Figure13).
Figure 12. Endocytic bypass assay.A:NormallySFVbinds to theplasmamembraneand is internalizedusingreceptor-mediatedendocytosis.TheendosomeprogressivelyacidifiesandapHlowerthan6.0causesaconformationalchangeinSFVspikeproteins,whichtriggersmembranefusionbetweenSFVenvelopeandthe endosomal membrane, freeing the nucleocapsid into the cytosol. The endosomal pathway can bebypassedbyallowingSFVvirionstobindtothehostPMinthecold,andsubsequentlytreatingtheinfectedcells with acidic medium for a short time. This leads to membrane fusion, and the release of the SFVnucleocapsid intothecytoplasm.Topreventendocytosedvirusesfromcompletingtheir infectionthroughtheendosomalroute,theacidicmediumisreplacedwithamediumcontainingNH4Cl.SomeoftheNH4+ionsare converted into NH3, a gas that can freely diffuse into the endosome and neutralize its acidification(Whiteetal,1980).B:Intheendocyticbypassassay,SFVvirionsareallowedtobindhostcellsonicefor60minutesandthevirus-containingmediumisremoved.Cellsaretreatedbriefly(90s)withacidicmedium,whichitisthenreplacedwithgrowthmedium(pH7.2)withorwithoutNH4Cl.Cellsareincubatedfor4hat+37°Candthenfixedusing4%PFA.
-
27
Figure13.HeLacellscanbeinfectedbyusingendocyticbypass.A:TherelativeinfectionpercentagesofHeLa cells infectedwith SFV-ZsGreen from two repetitions are indicated on the y-axis. The indicated pHvaluesrefertoinfectionwithnofusiononthePMbutincubationwithNH4Cl-containingmedium(pH7.0)and infection with PM fusion and incubation with NH4Cl-containing medium (pH 5.5). The infectionpercentageswerenormalizedbysettingthemeanof thenormal infectionsas1.Theerrorbarsrepresentstandard deviations of the two repetitions. B: Representative images of HeLa cells infected with SFV-ZsGreen.NucleiareshowninblueandnsP3-ZsGreen,indicatingSFVinfection,isshowningreen.Thetextintheimagesindicatesdifferentinfectionconditions(seeA).
4.3SLC6A13isneededintheearlystagesofSFVinfection
SLC6A13,alsoknownasGAT-2,isaGABAandtaurinetransporterthatcontains
12hydrophobicmembrane-spanningdomains,11loopregionsandcytoplasmic
NandCtermini(Kristensenetal,2011;Zhouetal,2012).Onthe3–4loopthere
arethreeN-glycosylatedresidues(Figure14)(Kristensenetal,2011).ThisPM
protein belongs to the solute-carrier 6 (SLC6) gene family, which contains
membrane proteins that transport neurotransmitters by utilizing Na+ and Cl-
ions(Kristensenetal,2011).AsitseemstoberequiredforSFVinfection,Itested
ifitisneededforentryandpenetrationstepsofinfection.ByinfectingHeLacells
using endocytotic bypass, I could revert SFV infectivity back to the level
observed in the scrambled controls (Figure 15). For further controls I used
siRNAsagainstATP6V1B2,ATP6V1G1,andUPF1.ATP6V1B2andATP6V1G1are
known to be critical for the penetration of SFV, and UPF1 works against SFV
-
28
infectioninthepost-penetrationstages(Balistrerietal,2014).Endocyticbypass
assay counteracted the effect of the siRNAs against ATP6V1B2 andATP6V1G1
(Figure15).Duetohighvariation,theSFVinfectivityonUPF1-depletedcellswas
not statistically different from controls in the endocytic bypass. However, the
meaninfectivitywassimilartothenormalinfectionassay(1.5-foldhigherthan
in controls) (Figure 15). Additionally, I used endocytic bypass to pinpoint
whether DDX54, an RNA helicase, affects the entry and penetration, or post-
penetration stages of SFV infection. The SFV infection inDDX54-depleted cells
didnotreverttothelevelofthecontrolswhenusingtheendocyticbypassassay
(Figure15).TheATP6V1B2,ATP6V1G1,andUPF1bypassresults,combinedwith
thefactthattheinfectivityinDDX54-depletedcellsremainedsignificantlylower
thanincontrolsshowthatendocyticbypassdoesnotreverttheeffectsofgene
knockdowninanunspecificmanner.Therefore,itcanbeusedtodistinguishthe
hostfactorsthatareneededfortheentryandpenetrationfromtheonesneeded
inthepost-penetrationstages.
Figure14.AschematicviewofSLC6A13.SLC6A13isamembraneproteinthatformsatransportchannel
forGABAandtaurineatthePM(adaptedfromKristensenetal,2011).
-
29
Figure 15. The roles of SLCA13 andDDX54 in SFV infection. A:The relative infectionpercentagesofsiRNA-treatedHeLacellsinfectedwithSFV-ZsGreennormally(black)orusingendocyticbypass(grey)areindicated on the y-axis. The siRNAs used are indicated on the x-axis. The infection percentages werenormalized by setting the mean of the scrambled controls as 1. The error bars represent standarddeviations of the tree repetitions and an asterisk signifies a result that is significantly different from thecontrol. B: HeLa cells infected with SFV-ZsGreen normally or using endocytic bypass (indicated on theright).NucleiareshowninblueandnsP3-ZsGreen,indicatingSFVinfection,isshowningreen.ThesiRNAsusedareindicatedbythetextintheimages.
-
30
4.4 TNP01 and HDAC6 affect the entry and penetration steps of SFVinfection.TNP01 is a cellular transportmolecule implicated innuclear transport,mitotic
spindleassembly,nuclearenvelopeassembly,ciliary import,andthe formation
ofPbodiesandstressgranules(Twyffelsetal,2014).HDAC6ismemberofthe
histone deacetylase (HDAC) family, but unlike other HDACs, it has also non-
histonictargetsandhasaubiquitin-bindingzinc-fingerdomain(Lietal,2013).
BothTNP01andHDAC6haverolesincellularstressresponses(Kawaguchietal,
2003;Twyffelsetal,2014)andseemtohaveroleinSFVinfection,eventhough
theeffectofHDAC6isminuscule. Intheendocyticbypassassay,SFVinfectivity
was not significantly different from the controls in both TNP01 and HDAC6-
depletedcells(Figure16).Thisindicatesthattheirrolesarerelatedtotheearly
stagesofSFVinfection.
4.5Componentsofthetranslationmachineryaffectpenetrationandpost-
penetrationstepsofSFVinfection
EIF2B3, EIF4G1, and RPL18 are components of the translational machinery
(Walsh&Mohr,2011;delaCruzetal,2015)(Figure17),andtheyappeartoplay
apartinSFVinfection.Astheircanonicalrolesarerelatedtohosttranslation,I
assumed that they would work similarly in SFV infection and affect the post-
penetrationstages.Itestedthisusingtheendocyticbypassassay.Thisapproach
revealed that EIF2B3 is not needed in SFV entry or penetration, as the
percentage of infected cells was three times that of controls in the endocytic
bypass assay (Figure 18). For the EIF4G1-depleted cells, the mean infection
percentageintheendocyticbypassassaywassimilartothatofnormalinfection
assay(1.5-foldhigher than incontrols),but thisdifferencewasnotstatistically
significant(Figure18).Surprisingly,bycircumventingendocytosis,Icouldfully
revert the infection-diminishing effect of the RPL18 knockdown (Figure 18),
indicating that this ribosomal subunit plays a part in the early stages of SFV
infection.
-
31
Figure 16. The roles of TNP01 and HDAC6 in SFV infection. A: The relative infectionpercentages ofsiRNA-treatedHeLacellsinfectedwithSFV-ZsGreennormally(black)orusingendocyticbypass(grey)areindicated on the y-axis. The siRNAs used are indicated on the x-axis. The infection percentages werenormalized by setting the mean of the scrambled controls as 1. The error bars represent standarddeviations of the tree repetitions and an asterisk signifies a result that is significantly different from thecontrol. B: HeLa cells infected with SFV-ZsGreen normally or using endocytic bypass (indicated on theright).NucleiareshowninblueandnsP3-ZsGreen,indicatingSFVinfection,isshowningreen.ThesiRNAsusedareindicatedbythetextintheimages.
-
32
Figure17.TherolesofeIF2B,eIF4,andRPL18ontheinitiationoftranslation.Duringtheinitiationofeukaryotic translation, a 43 S pre-initiation complex is formed by GTP-bound eIF2, the 40 S ribosomalsubunitandothertranslationfactors(Walsh&Mohr,2011).ThiscomplexbindseIF4andothertranslationfactors, formingthe48Spre-initiationcomplex(Walsh&Mohr,2011).FollowingGTPhydrolysisandthebinding of the 60 S subunit, GDP-bound eIF2 dissociates and translationmoves to the elongation phase(Walsh&Mohr, 2011).GDP-eIF2 is converted to activeGTP-eIF2by eIF2Band it can initiate translationagain(Walsh&Mohr,2011).RPL18isapartoftheribosomal largesubunit(delaCruzetal,2015).MosttranslationfactorsandmRNAareomittedforclarity.
-
33
Figure18.TherolesofdifferenttranslationalmachinerycomponentsinSFVinfection.A:Therelativeinfection percentages of siRNA-treated HeLa cells infected with SFV-ZsGreen normally (black) or usingendocytic bypass (grey) are indicated on the y-axis. The siRNAs used are indicated on the x-axis. Theinfectionpercentageswerenormalizedbysettingthemeanofthescrambledcontrolsas1.Theerrorbarsrepresentstandarddeviationsof the treerepetitionsandanasterisksignifiesaresult that issignificantlydifferent from the control.B: HeLa cells infected with SFV-ZsGreen normally or using endocytic bypass(indicatedontheright).NucleiareshowninblueandnsP3-ZsGreen, indicatingSFVinfection, isshowningreen.ThesiRNAsusedareindicatedbythetextintheimages.
4.6SFVinfectionisaffectedbyotherhostfactorsinpenetrationandpost-
penetrationsteps
SFV infectivity could be increased by using siRNAs against PHB2, EDF1, ETF1,
DDX47, DHX37, and DHX57. DDX47 and DHX57 are probable RNA helicases
(Gene IDs: 51202 and 90957, respectively), DDX54 is a RNA helicase that
functionsintranscriptionregulation(Rajendranetal,2003;Kannoetal,2012),
PHB2 and EDF1 are implicated in transcriptional processes (Kabe etal, 1999;
Bavelloni etal, 2015), andETF1 is known to interactwith nonsense-mediated
decay (Czaplinski et al, 1998), which is a part of the host antiviral defense
-
34
(Balistreri et al, 2014). Therefore my hypothesis was that all of these factors
wouldhavepost-penetrationaleffects.TheeffectsofPHB2andEDF1depletion
were similar in the endocytic bypass and normal infection (Figure 19) so I
concludedthattheireffectsarenotrelatedtoSFVentryorpenetration.InETF1,
DDX47andDHX37-depletedcellstheinfectivitywasnotstatisticallysignificantly
different from the controls, but for DDX47 and DHX37 it was still high and
comparable to the infectivity in thenormal infectionassay (2-foldand1.5-fold
higherthancontrols,respectively)(Figure19).Curiously,intheDHX57-depleted
cells,theeffectoftheendocyticbypasswastheoppositeofthenormalinfection,
astheinfectivitywassignificantlylowerthanincontrols(opposedtohigherthan
incontrolsinthenormalinfection).
ThedepletionofGNPDA1andDMN2decreasedSFVinfectivity.AsDMN2hasa
crucialroleinendocytosis(Kasaietal,1999),Iassumedthateffectofknockingit
downwouldbelimitedtotheearlystagesofSFVinfection.GNPDA1,ontheother
hand, isapoorly-characterizedglucosamine-6-phosphatedeaminase(Wolosker
et al, 1998) so it was difficult to hypothesize how it affects SFV infection. By
usingendocyticbypassassay,theeffectofthesiRNAtreatmentsagainstGNPDA1
and DMN2 were reversed, so it seems that they both have roles in the early
stagesofSFVinfection(Figure19).
-
35
Figure 19. The roles of PHB2, EDF1, ETF1, DDX47, DHX37, DHX57, GNPDA1, and DMN2 in SFVinfection. A: The relative infection percentages of siRNA-treated HeLa cells infected with SFV-ZsGreennormally(black)orusingendocyticbypass(grey)areindicatedonthey-axis.ThesiRNAsusedareindicatedonthex-axis.Theinfectionpercentageswerenormalizedbysettingthemeanofthescrambledcontrolsas1.Theerrorbarsrepresentstandarddeviationsofthetreerepetitionsandanasterisksignifiesaresultthatis significantly different from the control. B: HeLa cells infected with SFV-ZsGreen normally or usingendocytic bypass (indicated on the right). Nuclei are shown in blue and nsP3-ZsGreen, indicating SFVinfection,isshowningreen.ThesiRNAsusedareindicatedbythetextintheimages.
-
36
5.Discussion
5.1.HostfactorsinSFVandVSVinfections
Using siRNA knockdown, high-throughput imaging, and automated image
analysis,IstudiedtheeffectsofthedepletionofvarioushostfactorsonSFVand
VSVinfection(Table2).
Table2.TheeffectsofsiRNAtreatmentagainstvariousgenesonSFVandVSVinfection
Gene EffectonSFV
infection*
EffectonVSV
infection*
Gene EffectonSFV
infection*
EffectonVSV
infection*
PHB2 + - DDX41 0 0
EDF1 + 0 DDX43 0 0
SLC6A13 - DDX47 + 0
EIF2B3 + 0 DDX54 - 0
ETF1 + 0 DHX37 + -
EIF4G1 + 0 DHX57 + 0
DDX18 0 - KREMEN2 0 +
PVR 0
+ HDAC6
+ 0
CSPG5 0
0 DNM2 - 0
GNPDA1 -
0 AP2M1 0 +
RPL18 - - CLTC 0 0
UPF1 + 0 KPNB1 0 -
ATP6V1B2 - - TNPO1 - +
ATP6V1G1 - - Ppbi 0 +
DDX31 0 0 PPBI 0 +
*+=siRNAtreatmentincreasesinfection,-=siRNAtreatmentdecreasesinfection,0=siRNAtreatmenthasnoeffectoninfection
Byusingtheendocyticbypassassay,IpinpointedtherolesofSLC6A13,TNP01,
HDAC6, RPL18, ETF1, and GNDPA1 to the early events in SFV infection. I also
employedthesamemethodtoassignpost-penetrationrolesforDDX54,EIF2B3,
PHB2, and EDF1. My results also confirmed the previously reported roles of
ATP6V1B2andATP6V1G1 in the early stages of SFV infection (Balistrerietal,
2014). In the case of EIF4G1, DDX47, and DHX37 the mean infectivity in the
endocyticbypasswassimilartonormalinfection,eventhoughthedifferencewas
not statistically significant. In all cases this was caused by a single outlying
-
37
repetition(datanotshown),soIaminclinedtobelievethatthesefactorsaffect
the later stages of SFV infection. Similarly, in the endocytic bypass assay the
mean infectivity inUPF1-depletedcellswasnotsignificantlydifferent formthe
control because of a single outlier (data not shown). Still, themean infectivity
was similar to thenormal infection, andalmost two times thatof the controls.
Furthermore, UPF1 has been reported to prevent the translational and
transcriptional stagesof SFV infection (Balistrerietal, 2014). Curiously, in the
normal infection, DHX57 depletion increased SFV infection significantly but in
theendocyticbypass,virusinfectivitywassignificantlylowerthanincontrols.
5.2.SLC6A13isacandidatereceptorforSFV
SLC6A13 is structurally similar to the iron transporter NRAMP2 (natural
resistanceassociatedmacrophageprotein2)(Nevo&Nelson,2006;Kristensen
etal,2011).Theybothbelongto thesamefamilyofsolute-carryingmembrane
proteins that have 12 membrane-spanning domains and cytosolic N- and C-
termini (Nevo & Nelson, 2006; Kristensen et al, 2011). NRAMP2 is used as a
receptorinbothinsectandmammaliancellsbySindbisvirus,analphavirusthat
is closely related to SFV (Rose et al, 2012). Therefore SLC6A13 might be the
receptor for SFV.This is further supportedby the fact that SLC6A13depletion
does not affect VSV infectivity, as receptors are often virus-specific (Grove &
Marsh,2011).Additionally,SLC6A13mRNAistranscribedheavilyinthekidneys
(The Human Protein Atlas, http://www.proteinatlas.org/ENSG00000010379-
SLC6A13/tissue, Fagerberg et al, 2014). The currently used SFV strains have
been passaged multiple times in hamster kidney (BHK-21) cells (Atkins et al,
1999) and the reason thatBHK-21 cells supporthigh titers of SFVmaybe the
presence of the hamster analogue of SLC6A13. Passaging has affected SFV
bindingbyselectingforsingleaminoacidmutationsintheenvelopeproteinsof
the virus which allows SFV to bind to host heparan sulphate via simple
electrostaticinteractions(Smitetal,2002).Howeverbindingtohostreceptorsis
more complicated than binding on the surface, as it involvesmultiple specific
interactions between viral and host proteins (Marsh&Helenius, 2006). These
events need to be complex enough signal the host to initiate the endocytic
program(Marsh&Helenius,2006). It is thereforeconceivable thatadapting to
-
38
completelynewreceptors is anunlikelyeventeven in cell culture, andviruses
may retain specificity for suitable receptors on the surface of the cells from
whichtheyareproduced.
ToconfirmtheroleofSLC6A13inSFVinfection,furtherexperimentsareneeded.
WewilltestifSLC6A13-depletionblocksSFVentry(asopposedtopenetration)
using single-virus tracking in living cells and (Hoornweg et al, 2016).Wewill
also use fluorescent immunolabeling and confocalmicroscopy to compare the
rateofSFVendocytosisinSLC6A13-depletedandwildtypecells(Rizopouloset
al, 2015). Furthermore, will determine, if the transfection of a SLC6A13-
producing plasmidwill rescue SFV infection in conditional SLC6A13-knockout
cells. To further characterize the potential interaction between SLC6A13 and
SFV,astructuralapproachisneeded.Thismay,forexample,beintheformofX-
ray crystallography of the SFV spike proteins complexed with a SLC6A13
extracellular domain or domains (Peng et al, 2011), or a cryo-electron
microscopy single-particle reconstruction of SFV bound to SLC6A13 (He et al,
2002).
5.3.HostfactorsthataffectSFVinfection
ThefactthatTNP01RPL18,andETF1areneededforSFVentryandpenetration
stages issurprisingasTNP01 is involved in intracellular traffickingandRPL18
andETF1havecanonicalroles intranslation(Tayloretal,2012;Twyffelsetal,
2014; de la Cruz et al, 2015). TNP01 is used by adenoviruses (Hindley et al,
2007), human immunodeficiency virus 1 (HIV-1) (Arnold et al, 2006), and
humanpapillomavirus(Darshanetal,2004)forthenucleartransportofvarious
virus components. As the effect of TNP01 depletions are reversed by the
endocytic bypass assay, this cellular proteinmust be needed in the very early
stagesofSFVinfection.Therefore,aroleinthelaterstepsoftheviruslifecycle,
suchas interferencewithstressgranule formationorTNP01-mediatednuclear
import of viral replicase protein nsP2 (Twyffels et al, 2014; Fros & Pijlman,
2016),areunlikely tobe related to theobservedphenotypes. Itmightalsobe
thattheeffectofTNP01depletionisindirectanditaffectsthefunctionofsome
otherproteinsthathaverolesinSFVinfection.
-
39
In the case of VSV, the known role of TNP01 in stress granule formation, a
processthatisconsideredasamechanismofintrinsicantiviralimmunitymaybe
the reasonwhy TNP01 depletion increases VSV infection (Beckham& Parker,
2008;Twyffelsetal,2014).Ithaspreviouslybeenreportedthattheknockoutof
TIA-1, a stress granule-associated protein, increases the infectivity of VSV in
mouse embryonic fibroblasts (Li et al, 2002), which further supports this
hypothesis.
BasedontheinteractionofRPL18andotherviruses,onewouldexpectRPL18to
affect the late stages of SFV infection. This ribosomal proteinhas a role in the
translation or replication of Dengue virus (Cervantes-Salazar et al, 2015),
cauliflowermosaicvirus(Lehetal,2000)andHCV(Dharetal,2006).However,
inSFVinfection,RPL18functionsintheearlystagesofthevirallifecycle,which
indicates a mechanism different from the other known viruses. It has been
shownthatribosomesareneededintheuncoatingofSFVnucleocapsids(Singh
&Helenius,1992).Thus,RPL18mighthavearole inthisprocess,whichwould
beafunctionunlikeanydescribedforaribosomalproteinsofar.However,this
wouldalsomeanthatduringtheendocyticbypassassay,whenthenucleocapsids
aredelivereddirectlytothecytoplasmthroughthePM,SFVvirionsareuncoated
inadifferentwaythanduringthenormalentry.Thisunexpectedresultmayalso
be caused by an indirect interaction of RPL18 and some other cellular factor,
whichisperturbedbythedepletionofRPL18.AsIdidnotinvestigateatwhich
stageofVSVinfectionRPL18affects,myworkinghypothesis isthat itprobably
affectsthereplicationortranslation,ashasbeenreportedforotherviruses(Leh
etal,2000;Dharetal,2006;Cervantes-Salazaretal,2015).
ETF1isanotherproteinthatseemedtoberelatedtothepost-entrystagesofSFV
infection. ETF1 is a eukaryotic translation termination factor, with a role in
nonsense-mediated decay (Czaplinski etal, 1998), a pathway that is known to
counteract SFV infection during translation and replication (Balistreri et al,
2014). Thus, I initially assumed that ETF1 would have a role in the post-
penetrationstagesofSFVinfection.Myresultsruleoutthispossibility,because
the effect of ETF1 depletion was reversed by the endocytic bypass assay.
-
40
Therefore, itmight be that the effect I have observed is indirect, or ETF1 has
previouslyuncharacterizedfunctions.Additionally,thesefunctionsdonotseem
tobebroadlyantiviral,asETF1-depletionhadnoeffectonVSVinfection.
HDAC6isusedby influenzaAvirus(IAV)touncoat itsgenome(Banerjeeetal,
2014). It is also reported to inhibit oncolytic herpes simplex virus infection in
gliomacells,apparentlybyinterferingwithendocytictrafficking(Nakashimaet
al, 2015). As our initial result showed small but reproducible increase in SFV
infectionfollowedbyHDAC6knockdown,Iassumedthatitplaysaminorrolein
SFVentryandpenetrationprocessesasHDAC6hasarole in thepositioningof
endosomes (Li et al, 2013). This was confirmed by endocytic bypass.
SurprisinglyHDAC6depletiondidnotaffectVSV infection,eventhoughHDAC6
hasbeenreportedtoprotectmicefromVSV(Choietal,2016).Thismayindicate
that cell culturediffers significantly from invivoconditionsor thatHDAC6has
differentrolesinmouseandhumancells.ItisalsopossiblethatHDAC6functions
in the very late stages of VSV infection, such as egress, as our assay only
quantifiesviralreplicationandnotthelaterstagesofinfection.
DMN2isanotherproteinwithafunctioninendocytosis(Kasaietal,1999),and
therefore it was expected that its depletion would reduce SFV infectivity by
affecting theearlystepsof the infection.TheroleofDMN2 invirus infection is
well characterized, and it is needed for example by bovine ephemeral virus,
hepatitisEvirus,andPichindévirus(Velaetal,2008;Chengetal,2012;Hollaet
al,2015).SurprisinglyitwasnotrequiredbyVSV,eventhoughitisreportedto
becrucialforVSVentry(Curetonetal,2009;Johannsdottiretal,2009).
Incells,EIF2B3andEIF4G1function intranscription initiation(Walsh&Mohr,
2011).EIF2B3isacomponentofeIF2B,whichrecycleseIF2,akeyfactorinthe
formation of the 43 S pre-initiation complex and EIF4G1 has a function in
bringing the mRNA cap and poly-A tail together in the 48 S pre-initiation
complex(Walsh&Mohr,2011).Asapartofthehost’sbroadantiviralresponse
thataimstoshutdowntranslation,eIF2canbe inactivatedbyphosphorylation
(Walsh&Mohr,2011).SFVcancounteractthisresponse,andisknowntobeable
-
41
totranslateitsstructuralgeneseveninthepresenceofphosphorylatedeIF2.As
thedepletionofEIF2B3increasesSFVinfectioninthepost-penetrationstages,it
seems that SFV can translate even its early genes without a canonical set of
translationinitiationfactors.KnockingdownEIF4G1similarlyaffectslaterstages
of SFV infection and increases SFV infectivity. This shows that though cap-
dependent,thetranslationofSFVearlygenesdoesnotoccurinexactlythesame
way as the translation of hostmRNAs. Since SFV RNA is not as susceptible to
changesinthecompositionofthetranslationinitiationcomplexashostmRNAs
are,itgainsanadvantageinthetranslationalcompetition.Astheknockdownof
EIF4G1orEIF2B3doesnotaffectVSVinfection,theirfunctionismostlikelynot
broadlyantiviral.ThisindicatesthatSFVhasevolvedsomemechanismtobenefit
from the depletion of these host factorswhile VSV has not.Most likely this is
difference is mediated by the differences in SFV (sub)genomic RNA and VSV
mRNAs.
PHB2 knockdown increased SFV infectivity during the post-penetration steps
and it also increasedVSV infectivity.PHB2hasbeenreported tobeapro-viral
agent for HIV-1 (Emerson et al, 2010) and to associate with severe acute
respiratory syndrome coronavirus nsPs (Cornillez-Ty et al, 2009). Curiously,
PHB2-depletion has been previously shown to reduce VSV infection inmouse
cells (Kreit et al, 2015). The different result reported here might be due to
different roles of PHB2 in murine and human cells, or differences in VSV
infection between these two organisms. Additionally, Kreit et al (2015) used
small hairpin RNA technology, opposed to siRNAs used in this study. Even
though thesemethods are highly similar, thismay have a role in the differing
results. As PHB2 interacts with a myriad of host processes and proteins
(Bavellonietal,2015),itispossiblethattheeffectsofitsdepletionareindirect
and the actual effects are mediated by other host factors. PHB2 is also a
transcriptional regulator (Bavelloni et al, 2015) so its knockdown may just
reducehost translation, thusgiving theviralRNAsanedge in the translational
competition. This may also be the mechanism by which EDF1-depletion
promotesbothSFVandVSVinfectivity,asitisatranscriptionalactivator(Kabe
-
42
et al, 1999). This is further supported by the fact that the effect of EDF1
knockdownaffectsthelaterstagesofSFVinfection.
GNDPA1, DDX54, DDX47, DHX37, and DHX57 are all poorly characterized
cellular factors that have not been previously implicated in viral infections.
DDX47, DHX37, and DHX57 are predicted RNA helicases (Gene IDs: 51202,
57647, and 90957, respectively). DDX54 is an RNA-helicase that has been
reportedtobeatranscriptionalco-repressor(Rajendranetal,2003;Kannoetal,
2012). The knockdown of DDX53, and DDX47 increased SFV infection by
affecting the post-penetration stages, but had no effect on VSV infection. This
mayindicatethatbothofthesehelicasescantargetRNAstructuresfoundinSFV
but not in VSV. Or possibly SFV but not VSV requires these helicases for
translation or transcription. DHX37 depletion affected both SFV and VSV
infections.ItdecreasedSFVinfection,byaffectingthelatestages,andincreased
VSVinfection.Thismaybeduetoasimilarsituationasabove,butwithDHX37
depletion affecting host RNAs in a way, that allows VSV to succeed in the
translationalcompetitionagainstthehost.Itisdifficulttohypothesizethereason
why DHX57 depletion was beneficial to SFV in the normal infection, but
detrimentalintheendocyticbypass.ThismaybeduetoacomplexroleofDHX57
ormerely experimental anomalies. GNDPA1 is a highly conservedprotein that
plays a crucial role in metabolism (Wolosker et al, 1998). It is, therefore,
surprising that it would have a role in the early stages of SFV infection. This
effect would imply that GNDPA1 has previously uncharacterized functions, or
thatitsdepletionaffectsotherhostfactorsthat,inturn,affectSFVinfection.
5.4.Otherhostfactors
Apparently, VSV infection is counteracted by PVR, KREMEN2, AP2M1 and
cyclophilin B. On the other hand VSV seems to need ATP6V1B2, ATP6V1G1,
DDX18, and KPNB1 for successful infection. The requirement of the vATPase
subunits ATP6V1B2 and ATP6V1G1 by VSV is not surprising, as it penetrates
hostmembranesviapH-dependentfusion(Regan&Whittaker,2013).PVRand
KREMEN2arecellsurfacemolecules(Mendelsohnetal,1989;Maoetal,2002)
and AP2M1 is a part of AP2, and therefore has a role in clathrin-mediated
-
43
endocytosis (Heinaman,1995;Boucrotetal, 2010).Therefore it is conceivable
thatthesemoleculeswouldaffectVSVentryorpenetration.
DDX18isapoorly-studiedputativeRNAhelicaseforwhichhelicaseactivityhas
notbeendemonstratedyet(Dubaele&Chène,2007).IfDDX18doesaffectRNA,
the effect of its depletion on VSV but not SFV infection may be due to VSV
containing some RNAmotif that SFV lacks, or vice versa. KPNB1 is a protein
required for nuclear import (Görlich et al, 1995) and its depletion greatly
reducesVSVinfection.IthasbeenpreviouslyshownthattheMproteinofVSVis
transported into the nucleus, which allows it to reduce nucleocytoplasmic
transport(Petersenetal,2000;Glodowskietal,2002).Perhapsthetransportof
theMproteinismediatedbyKPNB1,whichreducesthetransportofhostmRNAs
into the nucleus, therefore giving VSV the upper hand in the translational
competition.
Cyclophilins affect the infections ofmultiple viruses (Frausto et al, 2013) and
cyclophilinAhasbeen reported tobe requiredbyVSV for successful infection
(Boseetal,2003).ThesiRNAsagainstPPBIincreasedinfectivitymorethanthe
siRNAsagainstPpbi.Mostlikelythiseffectisexplainedbysequencedissimilarity
between human andmouse cyclophilin B as the use of Ppbi-targeting siRNAs
wouldresultinonlypartialknockdownofPPBI(Petersenetal,2000;Glodowski
etal,2002).
CSPG6, a chondroitin sulfate proteoglycan (Watanabe et al, 1995), DDX31, an
RNA-helicasewithapossiblerole inrenalcarcinogenesis(Fukawaetal,2012),
DDX41aRNAhelicasewith functions in immuneprocesses (Jiangetal, 2017),
DDX43, an RNA and DNA helicase (Tanu et al, 2017), and CLTC, a well-
characterizedendocyticprotein(Doherty&McMahon,2009)didnothaveroles
inSFVofVSVinfections.Chondroitinsulfateproteoglycanshavebeenimplicated
inthebindingofvirusestohostcells(Banfieldetal,1995;Hsiaoetal,1999),but
SFVandVSVapparentlydonotutilize it,at leastexclusively.This isconsistent
withthereportthatSFVbindstoheparansulfateonthehostsurface(Smitetal,
2002). An siRNA screen showed a reduction in the infection of IAV (a double-
-
44
strandedDNAvirus) followedby the silencingofDDX31, but the investigators
didnotpursuethisresultanyfurther(Diotetal,2016)andDDX41seemstohave
aroleininnateimmunityinthedetectionofdouble-strandedDNAviruses(Jiang
etal,2017).AsSFVandVSVareRNAviruses,itseemsthatvirus-affectingroles
ofDDX31andDDX41might be exclusive toDNAviruses.DDX43hasnot been
previously implicated in viral infection so it is not surprising that it does not
affectSFVorVSVinfections.Clathrinhasbeenthoughttobecrucialfortheentry
ofbothSFVandVSV(Heleniusetal,1980;Sunetal,2005),butaccordingtomy
resultstheentryprocessmightbemorecomplicated,andCLTCisnotrequired
byeithervirus.
5.5.Methodologicalconsiderations
AssiRNA-basedscreeninghasbecomecheaperandsiRNAdesignhasimproved,
anumberoflarge-scalestudiesonhost-virusinteractionshavebeenpublishedin
recent years (Perreira et al, 2016). Even though siRNA-based screening is
definitelyapowerfultool, ithasitsdrawbacks.Traditionally,siRNAshavebeen
consideredveryspecificbutFranceschinietal(2014)showedthatsiRNAsused
inscreeningcanactasmicro-RNAs(miRNAs)andhavestrongoff-targeteffects.
This kind of indirect effects may explain the surprising results of siRNA
treatmentsagainstTNP01,RPL18,andETF1onSFVinfectionaswellasthoseof
siRNAsagainstPHB2andHDAC6onVSVinfection.Theapparentnonessentiality
of CLTC in both SFV and VSV infectionsmay also be explainedwith off-target
effects.Itmayalsobe,thatsomeofthesurprisingresultsareduetoincomplete
knockdown of the studied host factors. Due to possibility of off-targets or
incomplete knockdown, the results of siRNA screens need to be extensively
validated. The knockdown efficiency of the siRNAs should be tested using
immunoblotting.Preferably, therolesof thegenesof interestwouldbestudied
using knockout cells. As an ultimate test, a rescue assay needs performed, in
whichknockdownor(preferably)knockoutcellsaretransfectedwithaplasmid
thatproduces theprotein inquestion.This should lead to the reversionof the
effect on virus infection. Due to the lack of further validation, the genes
implicatedbymyexperimentsaretobeunderstoodascandidatefactors.
-
45
Theendocyticbypassassayusedinmyexperimentsisveryrobustandseparates
the function of the host factors to two rather broad categories. Therefore,
additional experiments are needed to perfectly understand the role of host
factors.Usingconfocalmicroscopy,itispossibletodetectifvirusesboundoncell
surface are endocytosed or not (Rizopoulos et al, 2015). To determine if the
depletion of the host factor affects SFV penetration or uncoating, specific
antibodies against the acidified spike proteins and SFV capsid proteins are
available (Liao & Kielian, 2006) Spike acidification is a sign of membrane
penetration,andthe localizationof thesignal fromanti-capsidantibodycanbe
used to detect the uncoating events (Singh&Helenius, 1992). Topinpoint the
effects of host factors to later stages of SFV infection, immunoblotting can be
used todetect theproductionofearlyand lateviralproteins. Similarly toSFV,
the endocytic part of VSV infection can be bypassed (Blumenthal etal, 1987).
Therefore,performinganendocyticbypassassaywouldbethenextstep inthe
elucidationoftherolesofthehostfactorsthataffectVSVinfection,followedwith
e.g.directmeasuringofVSVendocytosis(Rizopoulosetal,2015).
5.6.Conclusions
Themajor result of this study is that SLC6A13 is a candidate receptor for SFV
and if validated, it implies that alphaviruses in generaluse structurally similar
solutecarriersastheirreceptors.Thismayleadtothediscoveryofthereceptors,
of other,more clinically relevant alphaviruses,which in turnmay lead to new
therapeutic applications. Overall, it is clear that multiple previously
uncharacterized host factors affect both SFV and VSV infections and many of
thesefactorsarespecifictoSFVorVSV.Thisthesisalsoshowsthathostfactors
play important parts in both the early and late stages of SFV infection. Taken
together,theresultsofthisthesisfurtherconfirmthatvirus-hostinteractionsare
crucialinvirusinfections.Myfindingsserveasastartingpointtocontinuetoin-
depthstudiesintohowthesefactorsaffectSFVandVSVinfections.
6.AcknowledgementsI thank Dr. Giuseppe Balistreri for excellent supervision, Dr. Aušra Domanska,
ProfessorSarahButcher,Dr.JustinFlatt,andDr.CarlottaGlackinforthecritical
-
46
readingofmythesis,aswellasalltheothermembersoftheButchergroupfor
theirhelp and support. Iwould also like to acknowledge theLightMicroscopy
UnitoftheInstituteofBiotechnologyfortheuseoftheirequipmentandDr.Kirsi
Hellström,forthehelpprovidedintheamplificationofSFV-ZsGreen.
7.ReferencesArnoldM,NathA,HauberJ&KehlenbachRH(2006)MultipleImportinsFunctionas
NuclearTransportReceptorsfortheRevProteinofHumanImmunodeficiencyVirusType1.J.Biol.Chem.281:20883–20890
AtkinsGJ,SheahanBJ&LiljeströmP(1999)TheMolecularPathogenesisofSemlikiForestVirus:aModelVirusMadeUseful?J.Gen.Virol.80:2287–2297
BalistreriG,HorvathP,SchweingruberC,ZündD,McInerneyG,MeritsA,MühlemannO,AzzalinC&HeleniusA(2014)TheHostNonsense-MediatedmRNADecayPathwayRestrictsMammalianRNAVirusReplication.CellHostMicrobe16:403–411
BanerjeeI,MiyakeY,NobsSP,SchneiderC,HorvathP,KopfM,MatthiasP,HeleniusA&YamauchiY(2014)InfluenzaAVirusUsestheAggresomeProcessingMachineryforHostCellEntry.Science346:473–7
BanfieldB,LeducY,EsfordL,VisalliRJ,BrandtC&TufaroF(1995)EvidenceforanInteractionofHerpesSimplexViruswithChondroitinSulfateProteoglycansDuringInfection.Virology208:531–539
BavelloniA,PiazziM,RaffiniM,FaenzaI&BlalockWL(2015)Prohibitin2:AtaCommunicationsCrossroads.IUBMBLife67:239–254
BeckhamCJ&ParkerR(2008)P-bodies,StressGranulesandViralLifeCycles.CellHostMicrobe3:206–212
LeBlancI,LuyetP-P,PonsV,FergusonC,EmansN,PetiotA,MayranN,DemaurexN,FauréJ,SadoulR,PartonRG&GruenbergJ(2005)Endosome-to-CytosolTransportofViralNucleocapsids.Nat.CellBiol.7:653–664
BlumenthalR,Bali-PuriA,WalterA,CovellD&EidelmanO(1987)pH-DependentFusionofVesicularStomatitisViruswithVeroCells.MeasurementbyDequenchingofOctadecylRhodamineFluorescence.J.Biol.Chem.262:13614–13619
BoseS,MathurM,BatesP,JoshiN&BanerjeeAK(2003)RequirementforCyclophilinAfortheReplicationofVesicularStomatitisVirusNewJerseySerotype.J.Gen.Virol.84:1687–1699
BoucrotE,SaffarianS,ZhangR&KirchhausenT(2010)RolesofAP-2inClathrin-MediatedEndocytosis.PLoSOne5:e10597
CarpenterAE,JonesTR,LamprechtMR,ClarkeC,KangIH,FrimanO,GuertinDa,ChangJH,LindquistRa,MoffatJ,GollandP&SabatiniDM(2006)CellProfiler:ImageAnalysisSoftwareforIdentifyingandQuantifyingCellPhenotypes.GenomeBiol.7:R100
Cervantes-SalazarM,Angel-AmbrocioAH,Soto-AcostaR,Bautista-CarbajalP,Hurtado-MonzonAM,Alcaraz-EstradaSL,LudertJE&DelAngelRM(2015)DengueVirusNS1ProteinInteractsWiththeRibosomalProteinRPL18:ThisInteractionIsRequiredforViralTranslationandReplicationinHuh-7Cells.Virology484:113–126
ChengCY,ShihWL,HuangWR,ChiPI,WuMH&LiuHJ(2012)BovineEphemeralFeverVirusUsesaClathrin-MediatedandDynamin2-DependentEndocytosisPathwayThatRequiresRab5andRab7asWellasMicrotubules.J.Virol.86:13653–13661
ChoiSJ,LeeH,KimJ,ParkSY,KimT,LeeW,JangD,YoonJ,ChoiY,KimS,MaJ,KimC,YaoT,JungJU,LeeJ&LeeJ(2016)HDAC6RegulatesCellularViralRNASensingbyDeacetylationofRIG-I.35:429–442
-
47
CoordinatorsNR(2017)DatabaseResourcesoftheNationalCenterforBiotechnologyInformation.NucleicAcidsRes.45:D12–D17
Cornillez-TyCT,LiaoL,YatesJR,KuhnP&BuchmeierMJ(2009)SevereAcuteRespiratorySyndromeCoronavirusNonstructuralProtein2InteractswithaHostProteinComplexInvolvedinMitochondrialBiogenesisandIntracellularSignaling.J.Virol.83:10314–10318
CuretonDK,MassolRH,SaffarianS,KirchhausenTL&WhelanSPJ(2009)VesicularStomatitisVirusEntersCellsthroughVesiclesIncompletelyCoatedwithClathrinThatDependuponActinforInternalization.PLoSPathog.5:
CzaplinskiK,Ruiz-EchevarriaMJ,PaushkinSV.,HanX,WengY,PerlickHA,DietzHC,Ter-AvanesyanMD&PeltzSW(1998)TheSurveillanceComplexInteractswiththeTranslationReleaseFactorstoEnhanceTerminationandDegradeAberrantmRNAs.GenesDev.12:1665–1677
DarshanMS,LucchiJ,HardingE&MoroianuJ(2004)TheL2MinorCapsidProteinofHumanPapillomavirusType16InteractswithaNetworkofNuclearImportReceptorsTheL2MinorCapsidProteinofHumanPapillomavirusType16InteractswithaNetworkofNuclearImportReceptors.J.Virol.78:12179–12188
DharD,MapaK,PudiR,SrinivasanP,BodhinathanK&DasS(2006)HumanRibosomalProteinL18aInteractsWithHepatitisCVirusInternalRibosomeEntrySite.Arch.Virol.151:509–524
DiotC,FournierG,DosSantosM,MagnusJ,KomarovaA,vanderWerfS,MunierS&NaffakhN(2016)InfluenzaAVirusPolymeraseRecruitstheRNAHelicaseDDX19toPromotetheNuclearExportofViralmRNAs.Sci.Rep.6:33763
DohertyGJ&McMahonHT(2009)MechanismsofEndocytosis.Annu.Rev.Biochem.78:857–902
DubaeleS&ChèneP(2007)CellularStudiesofMrDb(DDX18).Oncol.Res.16:549–556EmersonV,HoltkotteD,PfeifferT,WangI-H,SchnolzerM,KempfT&BoschV(2010)
IdentificationoftheCellularProhibitin1/Prohibitin2HeterodimerasanInteractionPartneroftheC-TerminalCytoplasmicDomainoftheHIV-1Glycoprotein.J.Virol.84:1355–1365
FagerbergL,HallstromBM,OksvoldP,KampfC,DjureinovicD,OdebergJ,HabukaM,TahmasebpoorS,DanielssonA,EdlundK,AsplundA,SjostedtE,LundbergE,SzigyartoCA-K,SkogsM,TakanenJO,BerlingH,TegelH,MulderJ,NilssonP,etal(2014)AnalysisoftheHumanTissue-specificExpressionbyGenome-wideIntegrationofTranscriptomicsandAntibody-basedProteomics.Mol.Cell.Proteomics13:397–406
FranceschiniA,MeierR,CasanovaA,KreibichS,DagaN,AndritschkeD,DillingS,RamoP,EmmenlauerM,KaufmannA,Conde-AlvarezR,LowSH,PelkmansL,HeleniusA,HardtW-D,DehioC&vonMeringC(2014)SpecificInhibitionofDiversePathogensinHumanCellsbySyntheticMicroRNA-likeOligonucleotidesInferredfromRNAiScreens.Proc.Natl.Acad.Sci.111:4548–4553
FraustoSD,LeeE&TangH(2013)CyclophilinsasModulatorsofViralReplication.Viruses5:1684–1701
FrosJJ&PijlmanGP(2016)AlphavirusInfection:HostCellShut-OffandInhibitionofAntiviralResponses.Viruses8:166
FukawaT,OnoM,MatsuoT,UeharaH,MikiT,NakamuraY,KanayamaHO&KatagiriT(2012)DDX31Regulatesthep53-HDM2PathwayandrRNAGeneTranscriptionThroughItsInteractionwithNPM1inRenalCellCarcinomas.CancerRes.72:5867–5877
FullerSD,BerrimanJA,ButcherSJ&GowenBE(1995)LowpHInducesSwivelingoftheGlycoproteinHeterodimersintheSemlikiForestVirusSpikeComplex.Cell81:715–725
GeP,TsaoJ,ScheinS,GreenTJ,LuoM&ZhouZH(2010)Cryo-EMModeloftheBullet-ShapedVesicularStomatitisVirus.Science(80-.).327:689–693
-
48
GlodowskiDR,PetersenJM&DahlbergJE(2002)ComplexNuclearLocalizationSignalsintheMatrixProteinofVesicularStomatitisVirus.J.Biol.Chem.277:46864–46870
GörlichD,KostkaS,KraftR,DingwallC,LaskeyRA,HartmannE&PrehnS(1995)TwoDifferentSubunitsofImportinCooperatetoRecognizeNuclearLocalizationSignalsandBindThemtotheNuclearEnvelope.Curr.Biol.5:383–392
GosertR,EggerD,LohmannV,BartenschlagerR,BlumHE,BienzK&MoradpourD(2003)IdentificationoftheHepatitisCVirusRNAReplicationComplexinHuh-7CellsHarboringSubgenomicReplicons.J.Virol.77:5487–5492
GriffinDE(2013)Alphaviruses.InFieldsVirology,KnipeD&HowleyP(eds)pp651–686.Philadelphia:LippincottWilliams&Wilkins
GroveJ&MarshM(2011)TheCellBiologyofReceptor-mediatedVirusEntry.J.CellBiol.195:1071–1082
HeY,LinF,ChipmanPR,BatorCM,BakerTS,ShohamM,KuhnRJ,MedofME&RossmannMG(2002)StructureofDecay-acceleratingFactorBoundtoEchovirus7:aVirus-receptorComplex.Proc.Natl.Acad.Sci.U.S.A.99:10325–10329
HeinamanR(1995)ActivityandinVitroReassemblyoftheCoatedVesicle(H+)-ATPaseRequiresthe50-kDaSubunitoftheClathrinAssemblyComplexAP-2*.J.Biol.Chem.269:81–95
HeleniusA,KartenbeckJ,SimonsK&FriesE(1980)OntheEntryofSemlikiForestVirusIntoBHK-21Cells.J.CellBiol.84:404–420
HindleyCE,LawrenceFJ&MatthewsDA(2007)ARoleforTransportinintheNuclearImportofAdenovirusCoreProteinsandDNA.Traffic8:1313–1322
HoffmannH&Schiene-FischerC(2014)FunctionalAspectsofExtracellularCyclophilins.Biol.Chem.395:721–735
HollaP,AhmadI,AhmedZ&JameelS(2015)HepatitisEVirusEntersLiverCellsthroughaDynamin-2,ClathrinandMembraneCholesterol-dependentPathway.Traffic16:398–416
HoornwegTE,vanDuijl-RichterMKS,AyalaNuñezNV,AlbulescuIC,vanHemertMJ&SmitJM(2016)DynamicsofChikungunyaVirusCellEntryUnraveledbySingle-VirusTrackinginLivingCells.J.Virol.90:4745–56
HsiaoJC,ChungCS&ChangW(1999)VacciniaVirusEnvelopeD8LProteinBindstoCellSurfaceChondroitinSulfateandMediatestheAdsorptionofIntracellularMatureVirionstoCells.J.Virol.73:8750–8761
HubbertC,GuardiolaA,ShaoR,KawaguchiY,ItoA,NixonA,YoshidaM,WangX-F&YaoT-P(2002)HDAC6isaMicrotubule-associatedDeacetylase.Nature417:455–458
JiangY,ZhuY,LiuZJ&OuyangS(2017)TheEmergingrolesoftheDDX41ProteininImmunityandDiseases.ProteinCell8:83–89
JohannsdottirHK,ManciniR,KartenbeckJ,AmatoL&HeleniusA(2009)HostCellFactorsandFunctionsInvolvedinVesicularStomatitisVirusEntry.J.Virol.83:440–453
JohnsonDC&BainesJD(2011)Herpesvirusesremodelhostmembranesforvirusegress.Nat.Rev.Microbiol.9:382–394
KabeY,GotoM,ImaiT,WadaT,MorohashiK,ShirakawaM,HiroseS&HandaH(1999)TheRoleofHumanMBF1asaTranscriptionalCoactivatorTheRoleofHumanMBF1asaTranscriptionalCoactivator*.J.Biol.Chem.274:34196–34202
KannoY,SerikawaT,InajimaJ&InouyeY(2012)DP97,aDEADBoxDNA/RNAHelicase,IsaTargetGene-selectiveCo-regulatoroftheConstitutiveAndrostaneReceptor.Biochem.Biophys.Res.Commun.426:38–42
KasaiK,ShinHW,ShinotsukaC,MurakamiK&NakayamaK(1999)DynaminIIIsInvolvedinEndocytosisbutNotintheFormationofTransportVesiclesfromtheTrans-GolgiNetwork.JBiochem125:780–789
KawaguchiY,KovacsJJ,McLaurinA,VanceJM,ItoA&YaoTP(2003)TheDeacetylaseHDAC6RegulatesAggresomeFormationandCellViabilityinResponsetoMisfoldedProteinStress.Cell115:727–738
-
49
KreitM,VertommenD,GilletL&MichielsT(2015)TheInterferon-InducibleMouseApolipoproteinL9andProhibitinsCooperatetoRestrictTheiler’sVirusReplication.:1–22
KristensenAS,AndersenJ,JørgensenTN,SørensenL,EriksenJ,LolandCJ&StrømgaardK(2011)SLC6NeurotransmitterTransporters :Structure,Function,andRegulation.Pharma.Rev.63:585–640
KuhnRJ(2013)Togaviridae.InFieldsVirology,KnipeD&HowleyP(eds)pp629–650.Philadelphia:LippincottWilliams&Wilkins
KuismanenE,HedmanK,SarasteJ&PetterssonRF(1982)UukuniemiVirusMaturation:AccumulationofVirusParticlesandViralAntigensintheGolgiComplex.Mol.Cell.Biol.2:1444–58
delaCruzJ,KarbsteinK&WoolfordJL(2015)FunctionsofRibosomalProteinsinAssemblyofEukaryoticRibosomesInVivo.Annu.Rev.Biochem.84:93–129
LehV,YotP&KellerM(2000)TheCauliflowerMosaicVirusTranslationalTransactivatorInteractswiththe60SRibosomalSubunitProteinL18ofArabidopsisthaliana.Virology266:1–7
LeinonenR,AkhtarR,BirneyE,BowerL,Cerdeno-TarragaA,ChengY,ClelandI,FaruqueN,GoodgameN,GibsonR,HoadG,JangM,PaksereshtN,PlaisterS,RadhakrishnanR,ReddyK,SobhanyS,HoopenPTen,VaughanR,ZaluninV,etal(2011)TheEuropeanNucleotideArchive.NucleicAcidsRes.39:44–47
LiW,LiY,KedershaN,AndersonP,EmaraM,SwiderekKM,MorenoGT,BrintonMA&IrolJV(2002)CellProteinsTIA-1andTIARInteractwiththe3ЈStem-LoopoftheWestNileVirusComplementaryMinus-StrandRNAandFacilitateVirusReplication.76:11989–12000
LiY,ShinD&KwonSH(2013)HistoneDeacetylase6PlaysaRoleasaDistinctRegulatorofDiverseCellularProcesses.FEBSJ.280:775–793
LiaoM&KielianM(2006)Site-DirectedAntibodiesagainsttheStemRegionRevealLowpH-InducedConformationalChangesoftheSemlikiForestVirusFusionProtein.J.Virol.80:9599–9607
LylesD,KuzminI&RupprechtC(2013)Rhabdoviridae.InFieldsVirology,KnipeD&HowleyP(eds)pp885–922.Philadelphia:LippincottWilliams&Wilkins
ManciniEJ,ClarkeM,GowenBE,RuttenT&FullerSD(2000)Cryo-ElectronMicroscopyRevealstheFunctionalOrganizationofanEnvelopedVirus,SemlikiForestVirus.Mol.Cell5:255–266
MaoB,WuW,DavidsonG,MarholdJ,LiM,MechlerBM,DeliusH,HoppeD,StannekP,WalterC,GlinkaA&NiehrsC(2002)KremenProteinsAreDickkopfReceptorsthatRegulateWnt/β-cateninSignalling.Nature417:664–667
MarshM&HeleniusA(2006)VirusEntry:OpenSesame.Cell124:729–740MeadDG,RambergFB,BesselsenDG&MaréCJ(2000)TransmissionofVesicular
StomatitisVirusfromInfectedtoNoninfectedBlackFliesCo-feedingonNonviremicDeerMice.Science287:485–487
MeertensL,BertauxC&DragicT(2006)HepatitisCVirusEntryRequiresaCriticalPostinternalizationStepandDeliverytoEarlyEndosomesviaClathrin-CoatedVesicles.J.Virol.80:11571–11578
MendelsohnCL,WimmerE&RacanielloVR(1989)CellularReceptorforPoliovirus:MolecularCloning,NucleotideSequence,andExpressionofaNewMemberoftheImmunoglobulinSuperfamily.Cell56:855–865
MercerJ,SchelhaasM&HeleniusA(2010)VirusEntrybyEndocytosis.Annu.Rev.Biochem.79:803–833
NakashimaH,KaufmannJK,WangPY,NguyenT,SperanzaMC,KasaiK,OkemotoK,OtsukiA,NakanoI,FernandezS,GoinsWF,GrandiP,GloriosoJC,LawlerS,CripeTP&ChioccaEA(2015)HistoneDeacetylase6InhibitionEnhancesOncolyticViralReplicationinGlioma.J.Clin.Invest.125:4269–4280
NevoY&NelsonN(2006)TheNRAMPFamilyofMetal-ionTransporters.Biochim.
-
50
Biophys.Acta1763:609–620O’LearyNA,WrightMW,BristerJR,CiufoS,HaddadD,McVeighR,RajputB,RobbertseB,
Smith-WhiteB,Ako-AdjeiD,AstashynA,BadretdinA,BaoY,BlinkovaO,BroverV,ChetverninV,ChoiJ,CoxE,ErmolaevaO,FarrellCM,etal(2016)ReferenceSequence(RefSeq)DatabaseatNCBI:CurrentStatus,TaxonomicExpansion,andFunctionalAnnotation.NucleicAcidsRes.44:D733–D74